Support for 340B reform. Access and reimbursement for Part B and Part D drugs. Lobbied against the International Pricing Index model (83 FR 54546). H.R. 3, the Lower Drug Costs Now Act of 2019, and S.2543, the Prescription Drug Pricing Reduction Act of 2019.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
JOHN MCMANUS BARRETT THORNHILL JOHN MCMANUS BARRETT THORNHILL